MultiPark Debate! Aducanumab YES/NO – what is the best approach for an AD treatment?
Aducanumab YES/NO – what is the best approach for an AD treatment?
A debate about Aducanumab about the best approach for an Alzheimer’s treatment. Dr. Niklas Mattsson-Carlgren and Dr. Ruben Smith will each pose their arguments in favor and against. Dr. Smith defends the “PRO” argument and Dr. Mattsson-Carlgren defends “AGAINST” Aducanumab and other anti-amyloid treatments.
Alexa Pichet Binette and Lluís Camprubí Ferrer will moderate the debate.
- First part: 10 minutes where each debater pose their arguments in favor and against
- Second part: 20 minutes for rebuttal where you get to exchange opinions
- Third part: 20 minutes interaction with the audience
Coffee will be served.
The event is organized by the Young Multiparkers Group. Sign up here.